Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vitiligo.

R H Huggins1, R A Schwartz, C Krysicka Janniger

  • 1New Jersey Medical School, 185 South Orange Avenue, Newark, New Jersey 07103-2714, USA.

Acta Dermatovenerologica Alpina, Pannonica, Et Adriatica
|January 26, 2006
PubMed
Summary
This summary is machine-generated.

Vitiligo is a common autoimmune disorder causing melanocyte destruction, affecting all demographics, often starting before age 18. This review highlights recent therapeutic advancements for vitiligo management.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The humanistic burden of vitiligo: a systematic literature review of quality-of-life outcomes.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Perineal cutaneous basal cell carcinomas in patients with familial seronegative coeliac disease: report of three cases.

The British journal of dermatology·2021
Same author

Treatment options for leishmaniasis.

Clinical and experimental dermatology·2021
Same author

Generalized pustular figurate erythema first report in two COVID-19 patients on hydroxychloroquine.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

Interdigital syphilis: a rare form of secondary syphilis.

International journal of STD & AIDS·2019
Same author

Prolonged overall survival following metastasectomy in stage IV melanoma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same journal

Successful treatment of dupilumab-induced rosacea with upadacitinib in a patient with atopic dermatitis.

Acta dermatovenerologica Alpina, Pannonica, et Adriatica·2026
Same journal

Types of phacomatosis pigmentovascularis associated with nevus cesius.

Acta dermatovenerologica Alpina, Pannonica, et Adriatica·2026
Same journal

A biomarker-guided therapeutic map for alopecia: in vivo evidence and clinical implications.

Acta dermatovenerologica Alpina, Pannonica, et Adriatica·2026
Same journal

Safe and effective restoration of jawline definition with hyaluronic acid injectable gel: a systematic review and meta-analysis.

Acta dermatovenerologica Alpina, Pannonica, et Adriatica·2026
Same journal

Evaluation of the effects of cinobufagin on G361 melanoma cells and a comparison with paclitaxel.

Acta dermatovenerologica Alpina, Pannonica, et Adriatica·2026
Same journal

Acidity difference and skin Staphylococcus spp. colonization in preterm and term newborns.

Acta dermatovenerologica Alpina, Pannonica, et Adriatica·2026
See all related articles

Area of Science:

  • Dermatology
  • Immunology

Background:

  • Vitiligo is a common autoimmune condition characterized by melanocyte destruction.
  • It affects diverse populations, with onset often occurring before 18 years of age.
  • Misdiagnosis and stigma can arise in regions with endemic leprosy due to visual similarities.

Purpose of the Study:

  • To provide a comprehensive review of vitiligo.
  • To emphasize the latest therapeutic advances in vitiligo treatment.

Main Methods:

  • Literature review of vitiligo pathogenesis and current treatments.
  • Analysis of recent clinical trials and therapeutic strategies.

Main Results:

  • Vitiligo is a prevalent autoimmune disorder with early onset.
  • Therapeutic landscape is evolving with new treatment options.

    • Conclusions:

    • Vitiligo requires continued research into its autoimmune basis.
    • Emerging therapies offer improved management options for patients.